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Summary.-A nationwide study of nasopharyngeal cancer in Israel, during a 9-year
period (1960-68) demonstrated a mean annual incidence rate of 1.0 per 100,000 in
males and 0-4 per 100,000 in females. Significantly higher incidence was observed in
residents born in North Africa (3-0 in males and 1.1 in females). Survival was rela-
tively better in females among patients with lymphoepithelioma and in those without
neurological complications. The results may support the presence of environmental
factors in aetiology, though genetic predisposition cannot be ruled out.
NASOPHARYNGEAL canicer (NPC) is a
relatively rare disease with a distinctive
population distribution (Shedd, von Essen
and Eisenberg, 1967; Muir, 1972). Re-
peated studies have demonstrated a high
incidence among Chinese in diverse geo-
graphical locations (Clifford, 1970). Other
clusters have been described in South-east
Asia (Muir, 1971) Kenya (Clifford, 1967)
and in North Africa, particularly Tunisia
(Cammoun, Hioefner and Mourali, 1974).
V'iral agents suich as the Epstein-Barr
Virus (EBV) have been postulated as
possible aetiologic agents (Desgranges et
al., 1975) but genetic susceptibility has
also been suggested. The aim of the
present investigation was to study the
disease couirse aind distribution in the
Israeli population on a nationwide basis.
MIETHOI)
Records of all newly diagnosed :NPC
patients between 1960 and 1968 in all the 22
general hospitals in Israel were screened and
supplemented by a review of data available
at the Central Cancer Registry in Jerusalem.
All cases 1had ahistopathological confirmation.
Survival -was analysed with the aid of a life-
table method. 1 July 1974 was selected as a
cut-off point. Population data -were based on
reports of the Central Bureau of Statistics.
RESULTS
Incidence
150 new cases of NPC that met our
criteria were diagnosed in Israel during the
stu(ly period, yielding a mean annual
incidence of 1.0 per 100,000 in males and
0 4 in females. The youngest patient was
one month old at diagnosis and the oldest
was 85 years old. About 25° of the
patients were younger than 30, including
2 14-year-old Israel-born twins. There was
a continuous increase in incidence with age
in both sexes (Table I). Age-specific
incidence rates by age, sex and main
ethnic group are given in Tables If and
III, demonstrating a significantly (P(x2)
< 0-0001) higher rate in the North
African than in the European-born ofboth
sexes, and in the Asian-born males.
Incidence among Arabs (0.7/1]00,000) did
not differ significantly from any of the
Jewish groups. Length of residence in
Israel had no effect on incidence in either
major ethnic group.
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TABLE I.-Mean Annual Incidence Rate (per 100,000) ofNasopharyngeal
Carcinoma in Israel (1960-68) by Age and Sex (Jewish Patients only)
Age group (years)
0-9
10-19
20-29
30-39
40-49
50-59
60-69
70-80
Total
Males
No. RaeA
No. Rate
3
7
7
10
18
27
11
13
96
0-14
0-33
0-53
0-87
1 -64
2-55
1-77
4-26
0-98
Females
No. Rate
7
7
2
9
8
4
3
40
0-35
0-54
0-16
0-79
0-80
0-68
0-88
0-40
Total
No. Rate
3 0-07
14 0-34
14 0 57
12 0 50
27 1-21
35 1-70
15 1-24
16 2-48
136 0-70
TABLE II.-Mean Annual Incidence Rate (per 100,000) ofNasopharyngeal
Carcinoma in Israel (1960-68) by Age and Birthplace (Males)
Jews
Birthplace
Age group (years)
0-9
10-19
20-29
30-39
40-49
50-59
60-69
70-80
Total
Age-adjusted*
Europe/
Africa Asia America
No. Rate No. Rate No. Rate
2
7
5
7
13
1
3
38
0-58
2-36
2-17
4.37
12-16
1 -68
11 -42
2 -80
3 0
2
1
3
1
3
4
14
0-80
0-36
1 -58
0-66
2-77
5.99
1*01
0-8
3
5
12
4
6
30
0-66
0-74
1 -58
0-93
3 00
0-96
0-5
* Direct method; total Israeli population used as standard.
TABLE III.-Mean Annual Incidence Rate (per 100,000) ofNasopharyngeal
Carcinoma in Israel (1960-68) by Age and Birthplace (Females)
Age group (years)
0-9
10-19
20-29
30-39
40-49
50-59
60-69
70-80
Total
Age-adjusted*
Jews
Birthplace
Europe/
Africa Asia America Israel
No. Rate No. Rate No. Rate No. Rate
3
3
1
4
3
1
15
0-93
1-04
0-43
2-54
2-70
1 -60
1-13
1*1
1
3
4
1
3
12
0-44
0-97
2-06
0-94
4-27
0-88
0- 7
1
1
4
2
0-37
0-19
0-14
0-58
0-51
9 0-28
0-2
3
1
0-26
2-26
4 0-10
0-3
* Direct method: total Israeli population used as standard.
Israel
No. Rate
3 0-15
3 0-25
1 0-52
3 4.29
1 2-34
3 11-45
14 0-35
1-6
Arabs
No. Rate
1 0-20
2 0- 70
2 1-62
1 1-38
1 2-42
1 2-97
8 0-62
0-8
Arabs
No. Rate
1 0-54
1 0-79
3 3-70
1 2-29
6 0-48
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Histology and anatomic site
Lymphoepithelioma comprised 42% of
the cases, anaplastic carcinoma, 26.700
and squamous-cell carcinoma, 23.3%
(Table IV). In 8 cases, the histopatho-
TABLE IV.-Frequency Distribution of
NATPC Cases by Histological Type
Histological type Cases %
Lymphoepithelioma 63 42-0
Anaplastic carcinoma 40 26-7
Squamous-cell carcinoma 35 23 3
Sarcoma 4 2-7
AMiscellaneous and unspecified 8 5.3
Total 150 100-0
logical picture could not be specified.
Tumours of the lateral and posterior walls
occurred in 43.30/o of the cases, while in
28% of the tumours were diffused (Table
V). There were no significant differences
between males and females in either
histopathology or tumour location.
TABLE V.-Frequency Distribution ofNPC
Cases by Primary Location
Site of origin Cases %
Roof of nasopharynix 32 21-4
Lateral walls 51 34-0
Posterior wall 14 9-2
Widespread 42 28-0
Site not specified 11 7 4
Total 150 100*0
Symptomatology
In 5000 of the patients, diagnosis was
made within 3 months and in 90%O within
12 months of onset of symptoms. Cervical
lymphadenopathy constituted the most
common symptom and occurred in about
two thirds (6433%) of the cases. This was
followed by symptoms in the ENT system,
such as hearing impairment and sensation
of fullness in the ear in 320%, nasal
obstructions in 23.40%, epistaxis in 15.40o,
otalgia and serous otitis media, tinitus
and profound nasal discharge (6-70o
each). Headache was reported in 22% and
dysphagia in 10.5%. Sixteen per cent of
the patients presented with neurological
and visual disturbance as the only symp-
toms, but the majority of these developed
general symptoms and signs of the disease
subsequently.
Prognosis
Approximately 900 of the patients
received X-raytherapy, with dosesranging
from 4000 to 6500 rad over 6-8 weeks.
Eight patients had, in addition, radical
neck dissections, and 13 received adjuvant
chemotherapy. Survival was better in
females than in males, and in patients
younger than 40 years of age in both
sexes (Table VI).
TABLE VI.-Survival (0) oflNIPC Patients
by Selected Demographic and Clinical
Categories
3 years 5 years
47 41 -3 Total
Age:
< 40 years
40-59 years
> 60 years
Sex: Male
Female
62-0 50-0
45-0 38-0
37-0 32-0
45-0 38-0
60-0 44-7
Histology:
Lymphoepithelioma
Anaplastic carcinoma
Squamous-cell carcinoma
Wt'ithout neurological complications
lVith neurological complications
Delay in diagnosis:
<4 months
4 to 6 months
> 7 months
63 -3
43-0
36-0
60-0
35-0
55 -5
34-7
26-2
55-7
21 -3
55-0 42-0
50-0 46-0
47-0 27-0
Patients with lymphoepithelioma had a
better prognosis (63-3% at 3 years and
55-5/O at 5 years) contrasting with 43%
and 3500 respectively in anaplastic and
36% and 26% in squamous-cell carcinoma.
Survival was lower in patients with
tumour invasion of the skull and with
neurological complications. Length of
delay till diagnosis had no consistent
effect on prognosis.
DISCUSSION
The most intriguing aspect of our study
is the higher risk of NPC in the North
African-born population segment. This
excess, which is in line with Cammoun's
findings in Tunisia of 2 05 per 100,000
(Cammoun et al., 1974) could be attributed
either to environmental or genetic factors,
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or both (Henderson, 1974). A differential
genetic susceptibility seems a reasonable
assumption, in view of the presence of
NPC in a pair of twins. At least 36 sets of
familial cases, mostly among siblings, and
all but 6 in Orientals, have been recorded
in the medical literature. These have been
recently summarized by Brown et al.
(1976). The recently described increased
frequency of HLA2 antigen in NPC
patients (Simons et at., 1974) may also
suggest a genetic susceptibility.
On the other hand, the possibility of an
environmental influence is supported by
the change in incidence among migrant
Chinese (Ho, 1967; Buell, 1965) during a
period too short for a genetic change to
occur. Although the similarity in rates
among veteran and newly-immigrant
Israelis seems to point against such a
possibility, it should be recalled that the
effect was measured only for a period of
10 years after immigration. This length of
time may be too short to lead to a signi-
ficant change, while some of the environ-
mental factors may still persist. A second-
generation effect could not be evaluated
due to the limited number of Israel-born
patients. Nevertheless, the data are still
compatible with the hypothesis that the
factor under consideration is related to
that part of the environment that has
not yet been changed among the North
African-born.
Recent studies indicate a viral involve-
ment in NPC aetiology (i.e. presence of
high titres of EBV antibodies in patients
(de Schryver, Klein and Henle, 1974)).
Suchobservations areofparticularinterest,
since in Israel cervical cancer, a neoplasm
with a fairly well substantiated viral
aetiology, constitutes one of the few
malignant disorders that are more pre-
valent among the North African-born. A
link between these 2 malignancies is still
to be determined, but further viral
studies on a population basis may be
helpful.
The patients' survival is slightly higher
than reported by other investigators. One
possible explanation is the higher pro-
portion of lymphoepithelioma, which has
been consistently shown (Chen and
Fletcher, 1971; Wang, 1974) to have a
better survival, or the inclusion of rela-
tively more cases where surgical excision
of the tumour sufficed.
The aid of Dr Ruth Steinitz, and of the
Medical Record Libraries in all general
hospitals in Israel is deeply appreciated.
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